CTI

Robert Patton has been appointed vice president of business development at Clinical Trial and Consulting Services (CTI). Mr. Patton has more than 20 years of experience in healthcare and science related fields, and has an extensive background within CROs, biotechnology and pharma companies.

Most recently, Mr. Patton served as president and chief executive officer of Creative Strategies, LLC, where he was responsible for business development, consulting, and management of projects. He managed all stages — from protocol design to data lock to FDA submission — of more than 500 Phase I through Phase IV trials.

“We are very excited to have Bob join the CTI team. He has extensive experience in our industry which will be a great asset as CTI continues to grow,” said Lynn Fallon, executive vice president and president of consulting services at CTI.